Researchers say diet key to delaying chronic illness in old age
Want to age gracefully, as the saying goes, without any aches and pain?
While many know a balanced diet is a key factor in maintaining good health, a new Swedish study published in the journal, Nature Aging, looks at how diet can influence the development of chronic illnesses in aging populations.
The study by researchers at the Aging Research Center at the Karolinska Institutet followed more than 2,400 older adults over 15 years.
They were divided into four groups with different diets.
Those in three of the groups consumed healthy diets that focused on consuming vegetables, fruit, whole grains, nuts, legumes, unsaturated fats, and reduced their intake of sweets, red meat, processed meat, and butter or margarine.
The fourth group had a diet that was 'pro-inflammatory' and focused on consuming red and processed meat, refined grains and sweetened beverages, with a lower intake of vegetables, tea and coffee.
The three 'healthy' diets were the MIND diet (designed to protect brain health and to reduce the risk of dementia), the Alternative Healthy Eating Index (based on foods linked to lower disease risk) and the Alternative Mediterranean diet (a modified version of the Mediterranean diet adapted to Western eating habits).
'We found that people who consistently ate a healthy diet developed chronic diseases more slowly, in contrast to those whose diets were considered more inflammatory; that is, diets high in processed meats, refined grains and sugary drinks, which are known to promote low-grade chronic inflammation in the body,' the researchers said via The Conversation.
Recommended video
'This is important because having several health conditions at the same time is one of the biggest problems older people face. It increases the risk of disability, hospitalization and early death,' they added.
Chronic ailments such as cardiovascular disease and dementia did develop more slowly in this group, according to the researchers.
Participants who followed the pro-inflammatory diet increased their risk of chronic diseases.
The researchers didn't find a correlation between diet and musculoskeletal diseases such as arthritis or osteoporosis.
However, they noted that diet is only one part of healthy living, with other factors, such as physical activity, social connections, and access to health care, playing key roles in healthy aging.
For those considering making dietary changes to reduce their risk of chronic illnesses, the researchers suggest eating lots of vegetables, fruits, legumes, nuts and whole grains.
They also recommend consuming healthy fats like rapeseed oil and fish.
Foods they recommend limiting include red and processed meats, sugary drinks and solid fats.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
42 minutes ago
- Yahoo
NHS to recruit nurses and midwives before vacancies arise in new jobs boost
New measures will be introduced to allow NHS trusts to take on newly qualified nurses and midwives before vacancies arise, the Government has announced. NHS providers will be able to begin recruiting before vacancies formally arise as part of a 'graduate guarantee', the Department of Health and Social Care (DHSC) said. Its change to the recruitment process means trusts will be able to employ new staff based on projected need rather than current headcounts and is intended to ensure there are enough jobs for every newly qualified nurse and midwife in England. The DHSC said the move will remove barriers from trusts and open up thousands of positions for newly qualified nurses and midwives in the NHS. It said the package will also ensure the NHS has the right number of staff in hospitals across the country to provide the best possible care for patients. Further measures in the 'graduate guarantee' include newly qualified students receiving access to an online hub containing important information and advice for their applications to the roles, and an additional £8 million to temporarily convert vacant maternity support worker posts to Band 5 midwifery positions. The package comes following talks between the Government, the Royal College of Midwives (RCM) and the Royal College of Nursing (RCN). Record numbers decided to study nursing during the Covid pandemic, and fewer nurses and midwives are leaving the profession, meaning in some areas there are up to three times as many graduates as vacancies. Health Secretary Wes Streeting said: 'It is absurd that we are training thousands of nurses and midwives every year, only to leave them without a job before their career has started. 'No one who dedicates themselves to a nursing or midwifery career should be left in limbo, when their skills are so urgently needed in the effort to rebuild our NHS. 'I am sending a clear message to every newly qualified nurse and midwife: we're here to support you from day one so you can provide the best care for patients and cut waiting lists.' The DHSC says it hopes the measures will spread healthcare professionals across a wide variety of sectors. It cites that there are three times as many graduates as there are vacancies in some parts of the country, creating barriers for newly qualified healthcare professionals seeking jobs. The Government claims the reforms will provide greater certainty and access to a wide and diverse range of roles, addressing this issue of bottlenecks. Professor Nicola Ranger, general secretary of the RCN said the success of the scheme will be judged on whether more students are able to fill vacant positions in the NHS. She said: 'Our student members have led the way in calling for ministers and healthcare leaders to provide certainty and clarity on jobs. 'Today's announcement is welcome news that should provide hope to students as they come towards the end of their education and training. 'When the health service urgently needs nursing staff, it was absurd to leave people in limbo. 'The test of this will be if students can find jobs, vacant posts are filled, and patients receive the care they deserve.' RCM chief executive Gill Walton said: 'We're pleased that the Government has listened to the voices of student midwives who are desperate to start their career, only to find those opportunities blocked. 'I know today's announcement will come as a relief to so many of the RCM's student midwife members. 'These are people, mainly women, who have worked incredibly hard to complete their degree and are trained and ready to support our current midwifery workforce at a time when so many maternity services are under pressure. 'Ensuring we have the right midwifery staff, in the right places, at the right time with the right education and training has never been so crucial as services are striving to improve safety.'
Yahoo
42 minutes ago
- Yahoo
New drug ‘could boost effectiveness of chemotherapy', developers say
A take-at-home tablet could boost the way cancer patients respond to chemotherapy, according to the medical experts who developed it. The drug, known as KCL-HO-1i, works by disarming a defence mechanism that tumours use to protect themselves. Early tests on mice found the drug even helped chemotherapy-resistant tumours to respond to treatment. It is hoped KCL-HO-1i can be trialled on humans, with researchers suggesting it could one day be a 'valuable companion drug' to chemotherapy, helping patients to avoid more aggressive treatments. Chemotherapy is used to treat many kinds of cancer and works by disrupting the way cancer cells grow and divide. However, in some patients it is not as effective as it should be because the body's own immune cells can act as a barrier around tumours. These white blood cells, known as macrophages, produce a protein called heme oxygenase-1 (HO-1), which helps shield the tumour from the immune system and block the effects of chemotherapy. KCL-HO-1i, which has been created by experts at Kings College London (KCL), targets this protein to make tumours more responsive to treatment. Professor James Arnold, head of tumour immunology group at the university, said: 'We discovered that these macrophages in cancer play a key role in blocking chemotherapy. 'By targeting the enzyme they produce using KCL-HO-1i, we were able to help beneficial immune cells and chemotherapy drugs become significantly more effective. 'In laboratory models, even chemotherapy-resistant tumours became responsive to treatment, which is a really exciting step forward.' The drug has been designed for patients to take at home as a tablet between chemotherapy sessions. Early tests on mice, published in the journal Science Translational Medicine, found the drug made breast cancer tumours more responsive to different types of chemotherapy. Researchers are now hopeful that trials involving patients with breast cancer and other forms of the disease could begin within two years. James Spicer, a professor of experimental cancer medicine at KCL, said: 'Chemotherapy remains a key part of treatment for many patients with cancer, but too often it is not as effective or long-lasting as we might like. 'This research has identified a key reason for these limitations, and discovered a drug that we are keen to test in the clinic alongside established chemotherapy drugs.' Miraz Rahman, a professor of medicinal chemistry at KCL, added: 'If human trials are successful, KCL-HO-1i could become a valuable companion drug to existing cancer therapies – helping more patients to benefit from the treatments that are already available and reduce the need for more aggressive cancer therapies in the future.' The King's College London scientists have launched a spin-out company called Aethox Therapeutics. Tanya Hollands, research information manager at Cancer Research UK, which supported the study alongside funding from the Medical Research Council, said: 'Researchers are increasingly learning how to make better use of existing cancer treatments, whether it's using them differently or in combination with new medicines, like this work suggests. 'Using combination therapies can help bring improved treatment options to patients more quickly, safely and affordably, because some components of the treatment have already been tested and used in the clinic. 'While early stage, it's exciting to see this potential new way to disarm cancer's ability to avoid detection by the immune system with a new drug, while also boosting the effectiveness of chemotherapy, and we look forward to seeing how this work progresses.'

Wall Street Journal
2 hours ago
- Wall Street Journal
Scientists Are Finally Making Progress Against Alzheimer's
Buck up, baby boomers. Sixty may not be the new 40, but 80 could soon be the new 60. A trove of new Alzheimer's research suggests that medicines and lifestyle changes can not only slow but prevent, even reverse, the debilitating disease. Alzheimer's is characterized by a buildup of amyloid plaque and tangles of tau proteins in the brain. They trigger inflammation, which in turn causes cognitive decline and neuron death. Scientists don't know exactly what causes this destructive cascade. The disease's complexity stymied the quest for treatments for decades, but no more. Scientists are learning quickly.